|
Safety and Efficacy of Remote Ischemic Conditioning for Patients Taking Off-pump Coronary Artery Bypass Grafting
RECRUITINGN/ASponsored by First Affiliated Hospital Xi'an Jiaotong University
Actively Recruiting
PhaseN/A
SponsorFirst Affiliated Hospital Xi'an Jiaotong University
Started2023-11-22
Est. completion2028-12-31
Eligibility
Age18 Years – 70 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06141525
Summary
Remote ischemic conditioning (RIC) is the process of repeated ischemia and reperfusion in the peripheral vessels, which is proved in reducing IRI in vital organs. This IMPROVE trial plans to enroll 648 patients who are diagnosed with coronary artery disease and are going to take off-pump CABG in five centers in China, to access whether RIC can and improve short-term prognosis.
Eligibility
Age: 18 Years – 70 YearsHealthy volunteers accepted
Inclusion Criteria: * Diagnosed with coronary artery disease and require off-pump CABG surgery. * Between 18 and 75 years old; * Normal left ventricular systolic function (ejection fraction \>40%) and left ventricular end-diastolic internal diameter (\<60 mm) in the cardiac ultrasound tests; * No or mild heart valve and great vessel abnormalities which do not require surgical intervention; * Participants or their authorized relatives agree to participate in the clinical trial and sign the informed consent. Exclusion Criteria: * Severe tissue injuries. * Myalgia, fractures and other peripheral vascular lesions. * Bypass graft being the radial artery. * Stenosis or severe malformations of the subclavian, jugular and femoral arteries and veins. * Previous vagus nerve trunk dissection or vagus nerve block surgery. * Other surgical operations at the same time. * Patients with pre-existing severe cardiac insufficiency, acute coronary syndromes, malignant hypertension and cardiogenic shock. * Severe coagulation abnormality or severe anemia. * Severe mental disorder. * Malignant tumors. * Pregnant or lactating. * Increased risk of treatment for patients, according to investigators. * Refuse to sign the informed consent form.
Conditions4
Coronary Artery Bypass GraftingHeart DiseaseIschemia-Reperfusion InjuryRemote Ischemic Conditioning
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorFirst Affiliated Hospital Xi'an Jiaotong University
Started2023-11-22
Est. completion2028-12-31
Eligibility
Age18 Years – 70 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06141525